NEW YORK, June 13 – Cepheid of Sunnyvale, Calif., said Wednesday it has arranged for the Malaysian company BioSynTech to become the exclusive distributor of its Smart Cycler testing system in Malaysia and Singapore.
"With its established distribution channels and extensive experience selling and supporting state of the art systems-based products, we are pleased to have partnered with BioSynTech to enter the life-science research markets in Southeast Asia," Tom Gutshall, Cephied's CEO, said in a statement.
The announcement comes shortly after Cepheid experienced a sharp increase in revenues in first-quarter 2001 which it attributed to initial sales of the Smart Cycler system in Europe. In the first quarter Cepheid posted revenues of $3.3 million, up from $900,000 in the year ago period.
Cepheid said it was now setting its sights on the other side of the world in order to position itself in the middle of a growing market.
“We expect the growth of biotechnology and genome research in Malaysia and Singapore to spur exciting new applications of our Smart Cycler technology,” Gutshall said.
Cepheid began selling the Smart Cycler DNA testing system, a thermal cycling system, through distributors in May of 2000.
It is distributed in the United States and Canada by Fisher Scientific and in other Asian countries by Takara Shuzo.
BioSynTech, based outside of Kuala Lumpur, currently distributes life-science research products throughout Southeast Asia.